Arena says Merck ends atherosclerosis development
522767
Arena Pharmaceuticals, Inc.   said on Monday that Merck & Co. Inc.  has  pulled out of a partnership to develop an experimental drug for  atherosclerosis after results from a mid-stage clinical trail.
574875
NEW YORK - Merck suffered a huge blow last week when it had to pull its blockbuster painkiller Vioxx from the market after a big study showed that it doubled the risk of heart attacks and strokes.
424010
Merck said that it would stop selling Vioxx because a study found that it doubled patients' risk of heart attack and strokes.
125021
Merck & Co. MRK.N on Friday said  U.S. regulators have decided not to approve the company's  experimental arthritis drug, the successor to its recalled  Vioxx pill, until more safety and effectiveness data are  obtained.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
247288
Merck &amp; Co. withdrew its Vioxx painkiller, which generated $2.5 billion in sales last year, because of a link to heart attacks and strokes.
233794
Merck & Co Inc. Thursday pulled its  arthritis drug Vioxx off the market because it increases the  risk of heart attack and stroke, a move that sent its shares  plunging, erasing $25 billion of its market value.
238647
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the manufacturer, Merck & Co. , said on Thursday.
421836
Merck & Co.  on Friday said U.S. regulators have decided not to approve the company's experimental arthritis drug, the successor to its recalled Vioxx pill, until more safety and effectiveness data are obtained.
52205
A major maker of heparin, a blood thinner used widely in surgery and dialysis, has stopped making it after hundreds of patients reported severe allergic reactions to the drug.
557443
Top executives at pharmaceutical giant Merck & Co. Inc. decided in May 2000 against developing a study to test directly whether its Vioxx painkiller drug might pose a heart risk, The New York Times reported on Saturday.
765930
U.S. regulators said on Friday they  would review a study showing a Merck and Schering-Plough  cholesterol drug worked no better than a generic in preventing  the build-up of arterial plaque.
364643
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market after a study showed it doubled the risk of heart attack and stroke, a move that sent its
587141
Merck & Co. MRK.N said on Thursday  withdrew its arthritis drug Vioxx globally after a colon cancer  trial confirmed long-standing concerns the drug raises the risk  of heart attack and stroke.
710057
The maker of the popular arthritis drug Vioxx is removing it from markets worldwide after a new study found that long-term users face increased risks for heart attack and stroke.
524021
Merck & Co.  said on Friday it would delay seeking approval for a combination pill designed to lower "bad" cholesterol, increase "good" cholesterol and avoid a common side effect of one of the ingredients.
667642
In a surprising setback for the  world's largest drugmaker, Pfizer Inc.  halted  development on Saturday of its top experimental medicine, the  cholesterol drug torcetrapib, due to safety concerns.